What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
His scientific interests lie mostly in Internal medicine, Gastroenterology, Adenocarcinoma, Surgery and Cancer.
His study in Internal medicine focuses on Risk factor, Odds ratio, Esophagus, Esophageal disease and Epidemiology.
The study incorporates disciplines such as Incidence, Dysplasia, Barrett's esophagus, Disease and GERD in addition to Gastroenterology.
His Adenocarcinoma research focuses on Relative risk and how it connects with Absolute risk reduction.
He has included themes like Esophagectomy, Esophageal cancer, Cohort study and Hazard ratio in his Surgery study.
The Cancer study combines topics in areas such as Carcinoma, Proportional hazards model, Quality of life and General surgery.
His most cited work include:
- Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma (2597 citations)
- British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus (780 citations)
- Association between Body Mass and Adenocarcinoma of the Esophagus and Gastric Cardia (607 citations)
What are the main themes of his work throughout his whole career to date?
Jesper Lagergren focuses on Internal medicine, Cancer, Surgery, Gastroenterology and Cohort study.
His study brings together the fields of Oncology and Internal medicine.
Jesper Lagergren has researched Cancer in several fields, including Carcinoma, Quality of life, General surgery and Gynecology.
His Surgery research includes themes of Neoadjuvant therapy, Esophagectomy, Esophageal cancer and Hazard ratio.
His work in Gastroenterology covers topics such as Esophagus which are related to areas like Stomach.
His Cohort study research focuses on Cohort and how it relates to Cancer registry.
He most often published in these fields:
- Internal medicine (91.51%)
- Cancer (49.21%)
- Surgery (51.57%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (91.51%)
- Cohort study (52.36%)
- Hazard ratio (31.29%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Cohort study, Hazard ratio, Surgery and Confidence interval are his primary areas of study.
His study ties his expertise on Gastroenterology together with the subject of Internal medicine.
His studies deal with areas such as Gastric adenocarcinoma, Diabetes mellitus, Cause of death, Comorbidity and Risk factor as well as Cohort study.
His Surgery study integrates concerns from other disciplines, such as Neoadjuvant therapy and Esophagectomy.
His research in Confidence interval intersects with topics in Odds ratio, Prospective cohort study and Stage.
His research integrates issues of Body mass index and Barrett's esophagus in his study of Odds ratio.
Between 2017 and 2021, his most popular works were:
- Pan-cancer analysis of whole genomes (538 citations)
- Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a Western population. (46 citations)
- Obesity surgery and risk of cancer (45 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
His main research concerns Internal medicine, Hazard ratio, Confidence interval, Adenocarcinoma and Odds ratio.
The various areas that Jesper Lagergren examines in his Internal medicine study include Gastroenterology and Oncology.
In his research, Risk of mortality is intimately related to Esophagus, which falls under the overarching field of Gastroenterology.
His work carried out in the field of Hazard ratio brings together such families of science as Neoadjuvant therapy, Esophagectomy, Surgery and Fibrosis.
He interconnects Comorbidity and Receiver operating characteristic in the investigation of issues within Confidence interval.
His Adenocarcinoma research is classified as research in Cancer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
